Network analysis of possible anaphylaxis cases reported to the US - - PowerPoint PPT Presentation

network analysis of possible anaphylaxis cases reported
SMART_READER_LITE
LIVE PREVIEW

Network analysis of possible anaphylaxis cases reported to the US - - PowerPoint PPT Presentation

Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting System after H1N1 influenza vaccine Taxiarchis Botsis 1,2 & Robert Ball 1 1 Center for Biologics Evaluation and Research (CBER), U.S. Food and


slide-1
SLIDE 1

1

Taxiarchis Botsis1,2 & Robert Ball1

1Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration

2Department of Computer Science, University of Tromsø, Tromsø, Norway

MIE 2011 Oslo, Norway

Network analysis of possible anaphylaxis cases

reported to the US Vaccine Adverse Event Reporting System after H1N1 influenza vaccine

slide-2
SLIDE 2

2

Vaccine Adverse Event Reporting System (VAERS)

n VAERS stores adverse events (AEs)

reported by:

n health care providers n vaccine recipients n manufacturers

n Well-trained nurses code these reports:

n using the Medical Dictionary for Regulatory

Activities (MedDRA) and

n assign preferred terms (PTs) that represent

the AEs described in the narratives.

slide-3
SLIDE 3

3

Study hypothesis

n Identify patterns and n Detect safety signals

by applying Network Analysis to VAERS

slide-4
SLIDE 4

4

Methods: Dataset

n

6034 VAERS reports for H1N1 vaccine (November 22, 2009-January 31, 2010)

n

237 possible anaphylaxis reports

n

Anaphylaxis: acute allergic reaction after vaccination

n

Dataset of 237 reports used to identify patterns of PTs related to anaphylaxis

slide-5
SLIDE 5

5

Methods: Network Analysis

Report_1= [VAX1 VAX2 PT1 PT2 PT3] decomposed to combinations of: VAX1-PT1, VAX1-PT2, VAX1-PT3, VAX2- PT1, VAX2- PT2, VAX2- PT3 And

VAX1-VAX2

And PT1- PT2, PT1- PT3, PT2-PT3

Report_1+ Report_2+…+ Report_n

PT1 PT2 PT3 VAX1 VAX2 VAX1 16 33 5 50 VAX2 4 10 5 50 PT1 12 10 16 4 PT2 12 9 33 10 PT3 10 9 5 5 VAX1, VAX2: Vaccines PT1, PT2, PT3: MedDRA Preferred Terms (PT) representing adverse events

# reports containing this tie

slide-6
SLIDE 6

6

Methods: Network construction

n Nodes the PTs and vaccines n Edges their interconnections n Edge weight the number of occurrences

for each tie

slide-7
SLIDE 7

7

Methods: Network reduction

Application of the ‘islands’ algorithm* to anaphylaxis network:

n identifies all the maximal islands within a

predefined node interval for an edge weight threshold And combine it with:

n triangular weight – TW (= number of triangles

each edge of the original network is contained).

n TWs emphasize multiple interactions, filter out

weak connections and reveal the patterns.

* M. Zaversnik and V. Batagelj, Islands, Sunbelt XXIV, 2004.

slide-8
SLIDE 8

8

Results: Anaphylaxis network

N=301 nodes What a mess!

slide-9
SLIDE 9

9

Results: Reduced network

It is clear now!

N=30 nodes

Brighton Collaboration Criteria

slide-10
SLIDE 10

10

Summary

n Network analysis identifies patterns related to adverse

events after vaccination1

n Limitations:

n Statistical framework of network analysis n Retrospectively collected dataset

n Future goals:

n Evaluation of other approaches for network reduction and n Application to prospectively collected data for prediction

purposes.

  • 1R. Ball and T. Botsis, Can network analysis improve pattern recognition among adverse events following

immunization reported to VAERS? Clinical Pharmacology & Therapeutics. 2011 Aug;90(2):271-8.

slide-11
SLIDE 11

11

Acknowledgements

n We thank the Medical Officers at FDA

who evaluated the reports and those who reported them.

n Research Participation Program,

Center for Biologics Evaluation and Research, Oak Ridge Institute for Science and Education